Mullin, A. and Jean-Claude, B. (2020) “HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin”, McGill Journal of Medicine. Montreal, Canada, 4(1). doi: 10.26443/mjm.v4i1.673.